Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Puretech Health Plc ADR
(NQ:
PRTC
)
27.46
UNCHANGED
Streaming Delayed Price
Updated: 3:24 PM EDT, May 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Puretech Health Plc ADR
< Previous
1
2
3
4
5
Next >
PureTech Founded Entity Vedanta Biosciences Unveils State-of-the-Art Manufacturing Facility to Provide Clinical and Commercial Supply of Oral Therapies Based on Defined Bacterial Consortia
June 28, 2022
From
PureTech Health plc
Via
Business Wire
Results of Annual General Meeting
June 15, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300
June 14, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute “Long” COVID with Respiratory Complications
June 14, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating Officer
June 06, 2022
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the Jefferies Healthcare Conference
June 01, 2022
From
PureTech Health
Via
Business Wire
PureTech Founded Entity Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox
May 26, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
May 24, 2022
From
PureTech Health plc
Via
Business Wire
Vedanta Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
May 24, 2022
From
Vedanta Biosciences
Via
Business Wire
PureTech to Present at the UBS Global Healthcare Conference
May 17, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022
May 16, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Announces Share Buyback Program Update
May 09, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Announces Share Buyback Program of up to $50 Million
May 05, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022
May 04, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New Study
April 29, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Announces Annual Results for Year Ended December 31, 2021
April 26, 2022
From
PureTech
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Publishes Phase 1a/1b Results for Lead Program VE303 in Cell Host & Microbe and Highlights Planned Presentations of Phase 2 VE303 Results
April 13, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces American Journal of Psychiatry Publication of Data Demonstrating its Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults w/ Major Depressive Disorder When Combined w/ Antidepressant Medication
April 12, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Announces Publication of Research from Collaborators Demonstrating PureTech’s Glyph™ Platform Enhances Oral Absorption of Buprenorphine (a Clinically-Validated Opioid Replacement Therapy)
April 12, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Health: Notice of Results
April 07, 2022
From
PureTech Health
Via
Business Wire
PureTech Appoints Sharon Barber-Lui to Board of Directors & Audit Committee
March 24, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Appoints Game Industry Veteran Behind Bejeweled, Plants vs. Zombies as Chief Product Officer
March 17, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic
March 16, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Announces PLOS ONE Publication of Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functioning
February 17, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I
February 15, 2022
From
PureTech Health
Via
Business Wire
PureTech to Present at the SVB Leerink 11th Annual Global Healthcare Conference
February 10, 2022
From
PureTech Health
Via
Business Wire
PureTech Founded Entity Gelesis to Launch Plenity® National Media Campaign That Challenges Restrictive Dieting Norms
January 31, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I
January 26, 2022
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Gelesis, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of its Business Combination with Capstar
January 14, 2022
From
PureTech Health plc
Via
Business Wire
PureTech to Present at 40th Annual J.P. Morgan Healthcare Conference
January 07, 2022
From
PureTech Health plc
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.